Skip to content

FDA taking longer to fully approve a vaccine compared to approving emergency use is normal

Medical experts are expressing confusion on why the FDA is taking so long to approve the Covid-19 vaccines when the data is in.

Pfizer applied for full approval in May and Moderna in June. The FDA has set a goal of approval for 2022.

Jerome Adams, former Surgeon General, said he is unsure about why it took so long for the FDA to announce an approval timeline.

The vaccine was decided to be used for emergency use when Secretary Alex Azar declared the Covid-19 pandemic a public health emergency under the Trump Administration.

The difference between the FDA emergency use and FDA approval is that the approval process simply takes longer.

While many methods have been used to collect data and speed up the approval process, the slow turnaround still has people hesitant to get the vaccine.

Categories: HealthNews